Common side effects include nausea, diarrhea, and abdominal discomfort
Lonza and Catalent, large-capacity CDMOs, are upgrading sterile injectable fill lines specifically for GLP-1 injectables (nylon for prefilled syringes) in the US and Europe
Treatments like Wegovy, Zepbound, Mounjaro, and compounded Semaglutide and Tirzepatide mimic your body's natural fullness signals, making it easier to manage appetite, reduce calorie intake, and achieve a calorie deficit without constant hunger
Insomnia is not listed among common adverse reactions in FDA prescribing information for Mounjaro or Zepbound, and clinical trials did not identify it as a statistically significant side effect
Two separate GLP-1 MDL proceedings are currently underway in the Eastern District of Pennsylvania